Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Incyte Corporation
Instituto do Cancer do Estado de São Paulo
Tempus AI
Northwestern University
Mayo Clinic
pharmaand GmbH
Eastern Cooperative Oncology Group
Cancer Research UK, Glasgow
GOG Foundation
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Royal Marsden NHS Foundation Trust
National Cancer Institute (NCI)
National Cancer Institute (NCI)
GOG Foundation
Alliance for Clinical Trials in Oncology
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Dartmouth-Hitchcock Medical Center
University of California, San Francisco
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Royal Marsden NHS Foundation Trust
GOG Foundation
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
AGO Study Group
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)